Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/Australia/Survodutide
Purchase and availability checkSurvodutide in Australia

Can you buy Survodutide in Australia?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Survodutide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
Australia
Source records
3
Reviewed
24 July 2026
ByPeptide Local Editorial DeskUpdated 24 July 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Survodutide in Australia?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Survodutide is an investigational clinical program. No seller listing in Australia can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Survodutide in Australia?

Resolve the exact identity of Survodutide through SYNCHRONIZE-1 Phase 3 study - NCT06066515 from ClinicalTrials.gov. Then search Searching the Australian Register of Therapeutic Goods from Therapeutic Goods Administration for the destination product record and Personal Importation Scheme from Therapeutic Goods Administration for the seller, establishment, or supply route in Australia. A match in one record does not replace the other two checks.

03

Does an online listing prove Survodutide is authorized or available in Australia?

No. A page using the name Survodutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Australia, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Survodutide clinical trials in Australia

8 study records currently list 57 locations in this country, including 13 locations individually marked Recruiting.

Registry update: 24 July 2026
Study records
8
Listed locations
57
Recruiting locations
13
Records with local recruiting sites
2
NCT06632444
Study-wide statusRecruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Listed locations
9
Recruiting locations
7
Registry update
2026-07-09
NCT06632457
Study-wide statusRecruiting

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Listed locations
8
Recruiting locations
6
Registry update
2026-07-09
NCT06077864
Study-wide statusCompleted

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Listed locations
11
Recruiting locations
0
Registry update
2026-07-23
NCT06066528
Study-wide statusCompleted

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Listed locations
8
Recruiting locations
0
Registry update
2026-06-24
NCT06066515
Study-wide statusCompleted

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

Listed locations
7
Recruiting locations
0
Registry update
2026-03-12
NCT04771273
Study-wide statusCompleted

A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

Listed locations
3
Recruiting locations
0
Registry update
2024-12-03
Continue the exact comparison

Related country and compound records.

Compare another tracked name in Australia, or keep Survodutide fixed and change the destination within Asia-Pacific. The identity, product, and seller checks remain separate.

Continue the exact comparison

Survodutide in Asia-Pacific

Survodutide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Survodutide is an investigational clinical program. No seller listing in Australia can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: SYNCHRONIZE-1 Phase 3 study - NCT06066515 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

SYNCHRONIZE-1 Phase 3 study - NCT06066515

SYNCHRONIZE-1 Phase 3 study - NCT06066515 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open SYNCHRONIZE-1 Phase 3 study - NCT06066515 ↗

Searching the Australian Register of Therapeutic Goods

Searching the Australian Register of Therapeutic Goods is maintained by Therapeutic Goods Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Searching the Australian Register of Therapeutic Goods ↗

Personal Importation Scheme

Personal Importation Scheme is maintained by Therapeutic Goods Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Personal Importation Scheme ↗
Australia / Country guide

Australia market context.

Australian search results can combine therapeutic goods on the ARTG, practitioner or pharmacy services, conditional personal-import routes, and laboratory suppliers. Those categories answer different regulatory questions and should not share one price ranking.

  • The ARTG is the public reference database for therapeutic goods that can be supplied in Australia, subject to specific exemptions and access pathways.
  • The Personal Importation Scheme is conditional, limits typical quantities, prohibits counterfeit goods, and does not amount to TGA evaluation of the imported product.
  • No Australian commercial seller is ranked until local delivery, seller category, product status, pack size, and observation date can all be demonstrated.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Search the ARTG

Check the product, sponsor, ingredient, and ARTG identifier in the TGA database; goods not included generally cannot be supplied unless an exemption or access pathway applies.

02

Verify the practitioner

Use Ahpra’s public register to match the person, profession, current registration status, and state instead of relying on a clinic biography.

03

Read import conditions

Personal importation has quantity and eligibility conditions, and the TGA states imported products have not been evaluated for safety, quality, or efficacy.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT06066515: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightClinicalTrials.gov
02
Searching the Australian Register of Therapeutic GoodsTherapeutic Goods Administration
03
Personal Importation SchemeTherapeutic Goods Administration
04
Register of practitionersAustralian Health Practitioner Regulation Agency
05
Survodutide study search in AustraliaClinicalTrials.gov
06
NCT06632444: LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisClinicalTrials.gov
07
NCT06632457: LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisClinicalTrials.gov
08
NCT06077864: A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)ClinicalTrials.gov
09
NCT06066528: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose WeightClinicalTrials.gov
10
NCT04771273: A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)ClinicalTrials.gov
Audit and handoff

Keep the exact record attached.